Ruponen M - Search Results

1

Targeted delivery via avidin fusion protein: intracellular fate of biotinylated doxorubicin derivative and cellular uptake kinetics and biodistribution of biotinylated liposomes.

Soininen SK, Lehtolainen-Dalkilic P, Karppinen T, Puustinen T, Dragneva G, Kaikkonen MU, Jauhiainen M, Allart B, Selwood DL, Wirth T, Lesch HP, Määttä AM, Mönkkönen J, Ylä-Herttuala S, Ruponen M. Soininen SK, et al. Among authors: ruponen m. Eur J Pharm Sci. 2012 Dec 18;47(5):848-56. doi: 10.1016/j.ejps.2012.09.001. Epub 2012 Sep 14. Eur J Pharm Sci. 2012. PMID: 22985874

2

Interactions of polymeric and liposomal gene delivery systems with extracellular glycosaminoglycans: physicochemical and transfection studies.

Ruponen M, Ylä-Herttuala S, Urtti A. Ruponen M, et al. Biochim Biophys Acta. 1999 Jan 8;1415(2):331-41. doi: 10.1016/s0005-2736(98)00199-0. Biochim Biophys Acta. 1999. PMID: 9889391 Free article.

3

Efficient adventitial gene delivery to rabbit carotid artery with cationic polymer-plasmid complexes.

Turunen MP, Hiltunen MO, Ruponen M, Virkamäki L, Szoka FC Jr, Urtti A, Ylä-Herttuala S. Turunen MP, et al. Among authors: ruponen m. Gene Ther. 1999 Jan;6(1):6-11. doi: 10.1038/sj.gt.3300800. Gene Ther. 1999. PMID: 10341870

4

Extracellular and intracellular factors influencing gene transfection mediated by 1,4-dihydropyridine amphiphiles.

Hyvönen Z, Ruponen M, Rönkkö S, Suhonen P, Urtti A. Hyvönen Z, et al. Among authors: ruponen m. Eur J Pharm Sci. 2002 Jun;15(5):449-60. doi: 10.1016/s0928-0987(02)00031-3. Eur J Pharm Sci. 2002. PMID: 12036722

5

Nonviral gene delivery methods in cardiovascular diseases.

Ruponen M, Hyvönen Z, Urtti A, Ylä-Herttuala S. Ruponen M, et al. Methods Mol Med. 2005;108:315-28. doi: 10.1385/1-59259-850-1:315. Methods Mol Med. 2005. PMID: 16028692

6

Cell-surface glycosaminoglycans inhibit intranuclear uptake but promote post-nuclear processes of polyamidoamine dendrimer-pDNA transfection.

Ziraksaz Z, Nomani A, Ruponen M, Soleimani M, Tabbakhian M, Haririan I. Ziraksaz Z, et al. Among authors: ruponen m. Eur J Pharm Sci. 2013 Jan 23;48(1-2):55-63. doi: 10.1016/j.ejps.2012.10.016. Epub 2012 Nov 3. Eur J Pharm Sci. 2013. PMID: 23131796

7

Human placental cell and tissue uptake of doxorubicin and its liposomal formulations.

Soininen SK, Repo JK, Karttunen V, Auriola S, Vähäkangas KH, Ruponen M. Soininen SK, et al. Among authors: ruponen m. Toxicol Lett. 2015 Dec 3;239(2):108-14. doi: 10.1016/j.toxlet.2015.09.011. Epub 2015 Sep 14. Toxicol Lett. 2015. PMID: 26383631

8

Intracellular PK/PD Relationships of Free and Liposomal Doxorubicin: Quantitative Analyses and PK/PD Modeling.

Soininen SK, Vellonen KS, Heikkinen AT, Auriola S, Ranta VP, Urtti A, Ruponen M. Soininen SK, et al. Among authors: ruponen m. Mol Pharm. 2016 Apr 4;13(4):1358-65. doi: 10.1021/acs.molpharmaceut.6b00008. Epub 2016 Mar 16. Mol Pharm. 2016. PMID: 26950248

9

Melanin binding study of clinical drugs with cassette dosing and rapid equilibrium dialysis inserts.

Pelkonen L, Tengvall-Unadike U, Ruponen M, Kidron H, Del Amo EM, Reinisalo M, Urtti A. Pelkonen L, et al. Among authors: ruponen m. Eur J Pharm Sci. 2017 Nov 15;109:162-168. doi: 10.1016/j.ejps.2017.07.027. Epub 2017 Jul 27. Eur J Pharm Sci. 2017. PMID: 28756205

10

Corneal and conjunctival drug permeability: Systematic comparison and pharmacokinetic impact in the eye.

Ramsay E, Del Amo EM, Toropainen E, Tengvall-Unadike U, Ranta VP, Urtti A, Ruponen M. Ramsay E, et al. Among authors: ruponen m. Eur J Pharm Sci. 2018 Jul 1;119:83-89. doi: 10.1016/j.ejps.2018.03.034. Epub 2018 Apr 3. Eur J Pharm Sci. 2018. PMID: 29625211

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

92 results

Search Page

Filters